{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:44:58Z","timestamp":1785541498178,"version":"3.56.0"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>The purpose of this study was to evaluate antimicrobial prophylaxis regimens for genital gender affirmation surgery in the prevention of surgical site infections and other infectious complications and to provide a descriptive report of what was observed when using the study sites\u2019 recommended regimens.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective observational study was completed at 2 urban academic medical centers between June 1, 2020, and June 30, 2023. All data were collected through retrospective chart review. The primary outcome of this study was the prevalence of surgical site infections within 30 days following genital gender affirmation surgery completed by a single surgeon at 2 health centers. Secondary outcomes included the prevalence of surgical site infections within 6 months of surgery, potential relationships of demographic data and type of surgery with the development of postoperative infection, and relationships of antibiotics, dose, and number of subsequent doses with the development of postoperative infection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 146 surgeries (124 patients) were included in the final analysis. Surgical site infection occurred within 30 days postoperatively in 4 patients (3%), most commonly noted on the first follow-up visit within 1 month of surgery. Another 2 infections occurred within 6 months postoperatively, resulting in a total of 6 patients (4%) with surgical site infections during the study period.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This study observed an acceptable prevalence of surgical site infections within both 30 days and 6 months of genital gender affirmation surgery. This outcome supports the use of narrow gram-positive and gram-negative coverage (ie, cefazolin) for clean and clean-contaminated procedures without entry into the gastrointestinal (GI) or gastroduodenal (GU) tracts, with the addition of anaerobic coverage (ie, metronidazole) for clean-contaminated procedures with entry into the GI or GU tract, as clinically appropriate options.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaf063","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T07:31:07Z","timestamp":1741851067000},"page":"483-489","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of antimicrobial prophylaxis in genital gender affirmation surgery"],"prefix":"10.1093","volume":"82","author":[{"given":"Lauren","family":"Schmidt","sequence":"first","affiliation":[{"name":"Eskenazi Health , Indianapolis, IN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Blair","sequence":"additional","affiliation":[{"name":"Eskenazi Health , Indianapolis, IN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri","family":"Degenkolb","sequence":"additional","affiliation":[{"name":"Eskenazi Health , Indianapolis, IN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Foster","sequence":"additional","affiliation":[{"name":"Purdue University , West Lafayette, IN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lodolo","sequence":"additional","affiliation":[{"name":"Eskenazi Health , Indianapolis, IN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Macik","sequence":"additional","affiliation":[{"name":"Eskenazi Health , Indianapolis, IN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Rhew","sequence":"additional","affiliation":[{"name":"Eskenazi Health , Indianapolis, IN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Soyster","sequence":"additional","affiliation":[{"name":"Indiana University Health , Indianapolis, IN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Roth","sequence":"additional","affiliation":[{"name":"Indiana University Health , Indianapolis, IN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"issue":"18","key":"2025041702193697300_CIT0001","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in prevalence of health care-associated infections in U.S. hospitals","volume":"379","author":"Magill","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"2025041702193697300_CIT0002","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2146\/ajhp120568","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"70","author":"Bratzler","year":"2013","journal-title":"Am J Health-Syst Pharm"},{"issue":"2","key":"2025041702193697300_CIT0003","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/JU.0000000000000509","article-title":"Best practice statement on urologic procedures and antimicrobial prophylaxis","volume":"203","author":"Lightner","year":"2020","journal-title":"J Urol"},{"issue":"8","key":"2025041702193697300_CIT0004","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/jamasurg.2017.0904","article-title":"Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017","volume":"152","author":"Berrios-Torres","year":"2017","journal-title":"JAMA Surg"},{"issue":"1","key":"2025041702193697300_CIT0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jamcollsurg.2016.10.029","article-title":"American College of Surgeons and Surgical Infection Society: surgical site infection guidelines, 2016 update","volume":"224","author":"Ban","year":"2017","journal-title":"J Am Coll Surg"},{"issue":"5","key":"2025041702193697300_CIT0006","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrurol.2011.46","article-title":"Gender reassignment surgery: an overview","volume":"8","author":"Selvaggi","year":"2011","journal-title":"Nat Rev Urol"},{"issue":"4","key":"2025041702193697300_CIT0007","doi-asserted-by":"crossref","first-page":"e1738","DOI":"10.1097\/GOX.0000000000001738","article-title":"Trends in gender-affirming surgery in insured patients in the United States","volume":"6","author":"Lane","year":"2018","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2025041702193697300_CIT0008","volume-title":"Race and Ethnicity of Adults Who Identify as Transgender in the United States","author":"Flores","year":"2016"},{"issue":"2","key":"2025041702193697300_CIT0009","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/sur.2012.225","article-title":"Surgical site infections in genital reconstruction surgery for gender reassignment","volume":"15","author":"Zhao","year":"2014","journal-title":"Surg Infect"},{"issue":"9","key":"2025041702193697300_CIT0010","first-page":"e4594","article-title":"Temporal trends in gender affirmation surgery among transgender and non-binary minors","volume":"15","author":"Hassan","year":"2023","journal-title":"Cureus"},{"issue":"7","key":"2025041702193697300_CIT0011","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/andr.13214","article-title":"Hyperbaric oxygen therapy as adjuvant treatment for surgical site infections after male-to-female gender affirmation surgery: a 10-year experience","volume":"10","author":"Stizzo","year":"2022","journal-title":"Andrology"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxaf063\/62396883\/zxaf063.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/82\/8\/483\/62396883\/zxaf063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/82\/8\/483\/62396883\/zxaf063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T06:19:44Z","timestamp":1744870784000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/82\/8\/483\/8074482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":11,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,3,13]]},"published-print":{"date-parts":[[2025,4,17]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaf063","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4,15]]},"published":{"date-parts":[[2025,3,13]]}}}